03/27/2024
6:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
5:39 PM | NovoCure (Subject)
Shah Pritesh (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
5:17 PM | GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
3:43 PM | Cordova Ashley (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:33 PM | Giladi Moshe (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:33 PM | Leupin Nicolas (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:35 PM | NovoCure (Issuer)
Weinberg Uri (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/22/2024
6:11 AM | NovoCure (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/22/2024
6:05 AM | NovoCure (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2024
6:06 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
8:28 AM | FMR LLC (Filed by)
NovoCure (Subject)
| Form SC 13G/A | |
01/18/2024
6:01 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/12/2024
3:57 PM | Leonard Frank X (Reporting)
NovoCure (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/11/2024
4:15 PM | Leupin Nicolas (Reporting)
NovoCure (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/09/2024
6:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:10 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:10 PM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
3:23 PM | Giladi Moshe (Reporting)
NovoCure (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/11/2023
5:19 AM | Capital World Investors (Filed by)
NovoCure (Subject)
| Form SC 13G/A | |
11/28/2023
6:30 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
5:15 AM | BAILLIE GIFFORD & CO (Filed by)
NovoCure (Subject)
| Form SC 13G/A | |
11/08/2023
3:22 PM | NovoCure (Issuer)
Shah Pritesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
4:15 PM | NovoCure (Issuer)
Puri Michal Nath (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/02/2023
3:20 PM | Cordova Ashley (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2023
6:02 AM | NovoCure (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/26/2023
6:03 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2023
3:23 PM | NovoCure (Issuer)
Shah Pritesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:24 PM | GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:24 PM | Cordova Ashley (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
3:40 PM | Cordova Ashley (Reporting)
NovoCure (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2023
6:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/27/2023
6:02 AM | NovoCure (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/27/2023
6:03 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2023
7:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/06/2023
3:12 PM | Danziger Asaf (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
3:13 PM | Cordova Ashley (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
3:13 PM | Ben Arye Barak (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
3:14 PM | Burke William Patrick (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
3:14 PM | NovoCure (Issuer)
Shah Pritesh (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
3:14 PM | GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
3:15 PM | NovoCure (Issuer)
Weinberg Uri (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The #1 Opportunity of the decade? (Ad) It's no wonder the Department of Defense is heavily invested in this technology.
And why The Pentagon is pouring $20 billion into it. Click here to learn more >>> |
06/06/2023
2:45 PM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2023
11:18 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2023
7:00 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
3:34 PM | NovoCure (Issuer)
Stafford Kristin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/04/2023
6:02 AM | NovoCure (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023
6:02 AM | NovoCure (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2023
6:06 AM | NovoCure (Filer)
| Form DEF 14A | |
04/24/2023
6:08 AM | NovoCure (Filer)
| Form DEFA14A | |
